CAMLG Antikörper
-
- Target Alle CAMLG Antikörper anzeigen
- CAMLG (Calcium Modulating Ligand (CAMLG))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CAMLG Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (IF)
- Produktmerkmale
- Homo sapiens calcium modulating ligand (CAMLG)
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human CAMLG(NP_001736) produced in HEK293T cell.
- Klon
- 1H3
- Isotyp
- IgG2b
- Top Product
- Discover our top product CAMLG Primärantikörper
-
anti-Calcium Modulating Ligand (CAMLG) (AA 19-184) antibody
CAMLG Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Calcium Modulating Ligand (CAMLG) antibodyCAMLG Reaktivität: Human, Maus, Ratte WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Calcium Modulating Ligand (CAMLG) (AA 1-190) antibodyCAMLG Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Calcium Modulating Ligand (CAMLG) (AA 1-187) antibodyCAMLG Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Calcium Modulating Ligand (CAMLG) (AA 1-189) antibodyCAMLG Reaktivität: Human WB, ELISA, IP, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Calcium Modulating Ligand (CAMLG) (AA 1-296) antibodyCAMLG Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Calcium Modulating Ligand (CAMLG) (AA 1-296) antibodyCAMLG Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Calcium Modulating Ligand (CAMLG) (AA 1-100) antibodyCAMLG Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 3F12 unconjugated
anti-Calcium Modulating Ligand (CAMLG) (AA 1-188) antibodyCAMLG Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Calcium Modulating Ligand (CAMLG) (AA 111-138) antibodyCAMLG Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB22722 unconjugated
-
- Applikationshinweise
- WB 1:2000, IF 1:100, FLOW 1:100,
- Kommentare
-
The concentration of the product may vary between diferrent lots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5-1.0 mg/mL
- Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- CAMLG (Calcium Modulating Ligand (CAMLG))
- Andere Bezeichnung
- CAMLG (CAMLG Produkte)
- Synonyme
- MGC53900 antikoerper, CAML antikoerper, AI385748 antikoerper, Camlg antikoerper, Caml antikoerper, calcium modulating ligand L homeolog antikoerper, calcium modulating ligand antikoerper, camlg.L antikoerper, CAMLG antikoerper, camlg antikoerper, Caml antikoerper, Camlg antikoerper
- Hintergrund
- The immunosuppressant drug cyclosporin A blocks a calcium-dependent signal from the T-cell receptor (TCR) that normally leads to T-cell activation. When bound to cyclophilin B, cyclosporin A binds and inactivates the key signaling intermediate calcineurin. The protein encoded by this gene functions similarly to cyclosporin A, binding to cyclophilin B and acting downstream of the TCR and upstream of calcineurin by causing an influx of calcium. This integral membrane protein appears to be a new participant in the calcium signal transduction pathway, implicating cyclophilin B in calcium signaling, even in the absence of cyclosporin.
- Molekulargewicht
- 32.8 kDa
- Gen-ID
- 819
- NCBI Accession
- NM_001745
- HGNC
- 819
- Pathways
- EGFR Signaling Pathway
-
